A novel monoacylglycerol lipase-targeted 18F-labeled probe for positron emission tomography imaging of brown adipose tissue in the energy network. 2022

Ran Cheng, and Masayuki Fujinaga, and Jing Yang, and Jian Rong, and Ahmed Haider, and Daisuke Ogasawara, and Richard S Van, and Tuo Shao, and Zhen Chen, and Xiaofei Zhang, and Erick R Calderon Leon, and Yiding Zhang, and Wakana Mori, and Katsushi Kumata, and Tomoteru Yamasaki, and Lin Xie, and Shaofa Sun, and Lu Wang, and Chongzhao Ran, and Yihan Shao, and Benjamin Cravatt, and Lee Josephson, and Ming-Rong Zhang, and Steven H Liang
Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA.

Monoacylglycerol lipase (MAGL) constitutes a serine hydrolase that orchestrates endocannabinoid homeostasis and exerts its function by catalyzing the degradation of 2-arachidonoylglycerol (2-AG) to arachidonic acid (AA). As such, selective inhibition of MAGL represents a potential therapeutic and diagnostic approach to various pathologies including neurodegenerative disorders, metabolic diseases and cancers. Based on a unique 4-piperidinyl azetidine diamide scaffold, we developed a reversible and peripheral-specific radiofluorinated MAGL PET ligand [18F]FEPAD. Pharmacokinetics and binding studies on [18F]FEPAD revealed its outstanding specificity and selectivity towards MAGL in brown adipose tissue (BAT) - a tissue that is known to be metabolically active. We employed [18F]FEPAD in PET studies to assess the abundancy of MAGL in BAT deposits of mice and found a remarkable degree of specific tracer binding in the BAT, which was confirmed by post-mortem tissue analysis. Given the negative regulation of endocannabinoids on the metabolic BAT activity, our study supports the concept that dysregulation of MAGL is likely linked to metabolic disorders. Further, we now provide a suitable imaging tool that allows non-invasive assessment of MAGL in BAT deposits, thereby paving the way for detailed mechanistic studies on the role of BAT in endocannabinoid system (ECS)-related pathologies.

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008994 Monoacylglycerol Lipases An enzyme that catalyzes the hydrolysis of glycerol monoesters of long-chain fatty acids EC 3.1.1.23. Glycerol Monoester Hydrolase,Glycerol Monoester Hydrolases,Monoacylglycerol Lipase,Monoglyceride Esterase,Monoglyceride Esterases,Monoglyceride Lipase,Monoglyceride Lipases,Monoglyceride Hydrolase,Esterase, Monoglyceride,Esterases, Monoglyceride,Hydrolase, Glycerol Monoester,Hydrolase, Monoglyceride,Hydrolases, Glycerol Monoester,Lipase, Monoacylglycerol,Lipase, Monoglyceride,Lipases, Monoacylglycerol,Lipases, Monoglyceride,Monoester Hydrolase, Glycerol,Monoester Hydrolases, Glycerol
D002001 Adipose Tissue, Brown A thermogenic form of adipose tissue composed of BROWN ADIPOCYTES. It is found in newborns of many species including humans, and in hibernating mammals. Brown fat is richly vascularized, innervated, and densely packed with MITOCHONDRIA which can generate heat directly from the stored lipids. Brown Fat,Hibernating Gland,Brown Adipose Tissue,Fat, Brown,Tissue, Brown Adipose
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D049268 Positron-Emission Tomography An imaging technique using compounds labelled with short-lived positron-emitting radionuclides (such as carbon-11, nitrogen-13, oxygen-15 and fluorine-18) to measure cell metabolism. It has been useful in study of soft tissues such as CANCER; CARDIOVASCULAR SYSTEM; and brain. SINGLE-PHOTON EMISSION-COMPUTED TOMOGRAPHY is closely related to positron emission tomography, but uses isotopes with longer half-lives and resolution is lower. PET Imaging,PET Scan,Positron-Emission Tomography Imaging,Tomography, Positron-Emission,Imaging, PET,Imaging, Positron-Emission Tomography,PET Imagings,PET Scans,Positron Emission Tomography,Positron Emission Tomography Imaging,Positron-Emission Tomography Imagings,Scan, PET,Tomography Imaging, Positron-Emission,Tomography, Positron Emission
D063388 Endocannabinoids Fatty acid derivatives that have specificity for CANNABINOID RECEPTORS. They are structurally distinct from CANNABINOIDS and were originally discovered as a group of endogenous CANNABINOID RECEPTOR AGONISTS. Endocannabinoid

Related Publications

Ran Cheng, and Masayuki Fujinaga, and Jing Yang, and Jian Rong, and Ahmed Haider, and Daisuke Ogasawara, and Richard S Van, and Tuo Shao, and Zhen Chen, and Xiaofei Zhang, and Erick R Calderon Leon, and Yiding Zhang, and Wakana Mori, and Katsushi Kumata, and Tomoteru Yamasaki, and Lin Xie, and Shaofa Sun, and Lu Wang, and Chongzhao Ran, and Yihan Shao, and Benjamin Cravatt, and Lee Josephson, and Ming-Rong Zhang, and Steven H Liang
October 2019, Journal of medicinal chemistry,
Ran Cheng, and Masayuki Fujinaga, and Jing Yang, and Jian Rong, and Ahmed Haider, and Daisuke Ogasawara, and Richard S Van, and Tuo Shao, and Zhen Chen, and Xiaofei Zhang, and Erick R Calderon Leon, and Yiding Zhang, and Wakana Mori, and Katsushi Kumata, and Tomoteru Yamasaki, and Lin Xie, and Shaofa Sun, and Lu Wang, and Chongzhao Ran, and Yihan Shao, and Benjamin Cravatt, and Lee Josephson, and Ming-Rong Zhang, and Steven H Liang
June 2021, Acta pharmaceutica Sinica. B,
Ran Cheng, and Masayuki Fujinaga, and Jing Yang, and Jian Rong, and Ahmed Haider, and Daisuke Ogasawara, and Richard S Van, and Tuo Shao, and Zhen Chen, and Xiaofei Zhang, and Erick R Calderon Leon, and Yiding Zhang, and Wakana Mori, and Katsushi Kumata, and Tomoteru Yamasaki, and Lin Xie, and Shaofa Sun, and Lu Wang, and Chongzhao Ran, and Yihan Shao, and Benjamin Cravatt, and Lee Josephson, and Ming-Rong Zhang, and Steven H Liang
April 2016, ACS chemical neuroscience,
Ran Cheng, and Masayuki Fujinaga, and Jing Yang, and Jian Rong, and Ahmed Haider, and Daisuke Ogasawara, and Richard S Van, and Tuo Shao, and Zhen Chen, and Xiaofei Zhang, and Erick R Calderon Leon, and Yiding Zhang, and Wakana Mori, and Katsushi Kumata, and Tomoteru Yamasaki, and Lin Xie, and Shaofa Sun, and Lu Wang, and Chongzhao Ran, and Yihan Shao, and Benjamin Cravatt, and Lee Josephson, and Ming-Rong Zhang, and Steven H Liang
January 2004, Clinical nuclear medicine,
Ran Cheng, and Masayuki Fujinaga, and Jing Yang, and Jian Rong, and Ahmed Haider, and Daisuke Ogasawara, and Richard S Van, and Tuo Shao, and Zhen Chen, and Xiaofei Zhang, and Erick R Calderon Leon, and Yiding Zhang, and Wakana Mori, and Katsushi Kumata, and Tomoteru Yamasaki, and Lin Xie, and Shaofa Sun, and Lu Wang, and Chongzhao Ran, and Yihan Shao, and Benjamin Cravatt, and Lee Josephson, and Ming-Rong Zhang, and Steven H Liang
November 2017, Nuclear medicine and biology,
Ran Cheng, and Masayuki Fujinaga, and Jing Yang, and Jian Rong, and Ahmed Haider, and Daisuke Ogasawara, and Richard S Van, and Tuo Shao, and Zhen Chen, and Xiaofei Zhang, and Erick R Calderon Leon, and Yiding Zhang, and Wakana Mori, and Katsushi Kumata, and Tomoteru Yamasaki, and Lin Xie, and Shaofa Sun, and Lu Wang, and Chongzhao Ran, and Yihan Shao, and Benjamin Cravatt, and Lee Josephson, and Ming-Rong Zhang, and Steven H Liang
July 2019, Cell metabolism,
Ran Cheng, and Masayuki Fujinaga, and Jing Yang, and Jian Rong, and Ahmed Haider, and Daisuke Ogasawara, and Richard S Van, and Tuo Shao, and Zhen Chen, and Xiaofei Zhang, and Erick R Calderon Leon, and Yiding Zhang, and Wakana Mori, and Katsushi Kumata, and Tomoteru Yamasaki, and Lin Xie, and Shaofa Sun, and Lu Wang, and Chongzhao Ran, and Yihan Shao, and Benjamin Cravatt, and Lee Josephson, and Ming-Rong Zhang, and Steven H Liang
January 2013, Nature communications,
Ran Cheng, and Masayuki Fujinaga, and Jing Yang, and Jian Rong, and Ahmed Haider, and Daisuke Ogasawara, and Richard S Van, and Tuo Shao, and Zhen Chen, and Xiaofei Zhang, and Erick R Calderon Leon, and Yiding Zhang, and Wakana Mori, and Katsushi Kumata, and Tomoteru Yamasaki, and Lin Xie, and Shaofa Sun, and Lu Wang, and Chongzhao Ran, and Yihan Shao, and Benjamin Cravatt, and Lee Josephson, and Ming-Rong Zhang, and Steven H Liang
June 2009, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
Ran Cheng, and Masayuki Fujinaga, and Jing Yang, and Jian Rong, and Ahmed Haider, and Daisuke Ogasawara, and Richard S Van, and Tuo Shao, and Zhen Chen, and Xiaofei Zhang, and Erick R Calderon Leon, and Yiding Zhang, and Wakana Mori, and Katsushi Kumata, and Tomoteru Yamasaki, and Lin Xie, and Shaofa Sun, and Lu Wang, and Chongzhao Ran, and Yihan Shao, and Benjamin Cravatt, and Lee Josephson, and Ming-Rong Zhang, and Steven H Liang
January 2022, Acta pharmaceutica Sinica. B,
Ran Cheng, and Masayuki Fujinaga, and Jing Yang, and Jian Rong, and Ahmed Haider, and Daisuke Ogasawara, and Richard S Van, and Tuo Shao, and Zhen Chen, and Xiaofei Zhang, and Erick R Calderon Leon, and Yiding Zhang, and Wakana Mori, and Katsushi Kumata, and Tomoteru Yamasaki, and Lin Xie, and Shaofa Sun, and Lu Wang, and Chongzhao Ran, and Yihan Shao, and Benjamin Cravatt, and Lee Josephson, and Ming-Rong Zhang, and Steven H Liang
May 2019, Journal of medicinal chemistry,
Copied contents to your clipboard!